4 unchanged sentences
Number Filing Date
−Removed: 10.1+ Amended and Restated Outside Director Compensation Policy
+Added: 10.1# Side Letter between the Registrant and F-star Gamma Limited, dated June 30, 2021
— — — Filed herewith
−Removed: 10.2+ Amended and Restated Key Executive Change in Control and Severance Plan.
−Removed: 10-Q 001-38311 10.6 11/5/20
31.1 Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act.
17 unchanged sentences
— — — Furnished herewith
−Removed: 104 The cover page from the Company's Quarterly Report on Form 10-Q for the three months ended March 31, 2021, formatted in Inline XBRL (contained in Exhibit 101)
+Added: 104 The cover page from the Company's Quarterly Report on Form 10-Q for the three months ended June 30, 2021, formatted in Inline XBRL (contained in Exhibit 101)
— — — Furnished herewith
1 unchanged sentence
under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Form 10-Q, irrespective of any general incorporation language contained in such filing.
−Removed: + Indicates management contract or compensatory plan.
+Added: # Portions of this exhibit (indicated by asterisks) have been omitted in connection with the rules of the SEC.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
DENALI THERAPEUTICS INC.
−Removed: May 5, 2021 By:
+Added: August 4, 2021 By:
President and Chief Executive Officer
(Principal Executive Officer)
−Removed: May 5, 2021 By:
+Added: August 4, 2021 By:
Chief Financial Officer and Treasurer
1 unchanged sentence
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.